RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+4.61%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.3B
AUM Growth
+$1.3B
(-1.8%)
Cap. Flow
-$15.3M
Cap. Flow
% of AUM
-1.18%
Top 10 Holdings %
Top 10 Hldgs %
52.92%
Holding
72
New
14
Increased
18
Reduced
22
Closed
16
Top Buys
| 1 |
Boston Scientific
BSX
|
$41.5M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$40.3M |
| 3 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
$38.2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$29.3M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$26.3M |
Top Sells
| 1 |
RAD
Rite Aid Corporation
RAD
|
$49M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
$40.8M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$38.8M |
| 4 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$33.8M |
| 5 |
Incyte
INCY
|
$27.7M |
Sector Composition
| 1 | Healthcare | 79.19% |
| 2 | Communication Services | 1.61% |
| 3 | Industrials | 0.58% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $99.7M | 7.46% | 10,280,620 +1,947,690 | +23% | +$18.9M |
|
|
MDVN
2
DELISTED
MEDIVATION, INC.
MDVN
| $77.3M | 5.79% | 1,599,393 -153,249 | -9% | -$7.41M |
|
3
Penumbra
PEN
$10.6B
| $76.2M | 5.7% | 1,537,570 -25,017 | -2% | -$1.24M |
|
|
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
| $75.3M | 5.64% | 17,850,650 +100,140 | +0.6% | +$423K |
|
|
ITCI
5
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $65.8M | 4.93% | 1,223,717 -98,875 | -7% | -$5.32M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $62.9M | 4.7% | 1,795,936 +838,302 | +88% | +$29.3M |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $61.6M | 4.61% | 1,372,492 -17,681 | -1% | -$794K |
|
8
Teva Pharmaceuticals
TEVA
$21.1B
| $61.6M | 4.61% | 938,139 -199,420 | -18% | -$13.1M |
|
|
SAGE
9
DELISTED
Sage Therapeutics
SAGE
| $55.9M | 4.18% | 958,374 -184,490 | -16% | -$10.8M |
|
|
PTLA
10
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $49.3M | 3.69% | 958,155 +188,514 | +24% | +$9.7M |
|
|
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
| $44M | 3.29% | 562,873 +48,600 | +9% | +$3.8M |
|
|
12
Ironwood Pharmaceuticals
IRWD
$214M
| $42.6M | 3.18% | 3,671,344 +3,480,555 | +1,824% | +$40.3M |
|
|
13
Boston Scientific
BSX
$156B
| $41.5M | 3.11% | +2,251,020 | New | +$41.5M |
|
14
Atara Biotherapeutics
ATRA
$84.6M
| $40.5M | 3.03% | 1,534,962 +485,180 | +46% | +$12.8M |
|
|
15
Incyte
INCY
$16.5B
| $38.8M | 2.9% | 357,912 -255,686 | -42% | -$27.7M |
|
|
DPLO
16
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $38.2M | 2.86% | +1,115,902 | New | +$38.2M |
|
|
NVRO
17
DELISTED
NEVRO CORP.
NVRO
| $28M | 2.1% | 415,198 +390,198 | +1,561% | +$26.3M |
|
|
NDRM
18
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $27.1M | 2.03% | 1,589,261 +126,562 | +9% | +$2.16M |
|
19
Centene
CNC
$14.3B
| $26.9M | 2.01% | 408,000 -339,460 | -45% | -$22.3M |
|
20
Insmed
INSM
$28.8B
| $25.3M | 1.89% | 1,391,813 +443,847 | +47% | +$8.06M |
|
21
UnitedHealth
UNH
$281B
| $22M | 1.65% | +187,034 | New | +$22M |
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $21.5M | 1.61% | +68,758 | New | +$21.5M |
|
|
MODN
23
DELISTED
MODEL N, INC.
MODN
| $20.8M | 1.56% | 1,868,159 +424,881 | +29% | +$4.74M |
|
|
ZLTQ
24
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $20.2M | 1.51% | +709,426 | New | +$20.2M |
|
|
NSTG
25
DELISTED
NanoString Technologies, Inc.
NSTG
| $20M | 1.49% | 1,357,692 -27,949 | -2% | -$411K |
|